AI Solutions for Biotech

Tuesday, Jan 28, 2020
5:30 PM - 7:30 PM


Convergence of AI for applications in biotech is well beyond science fiction. Currently, over 90% of molecules discovered using traditional techniques fail in human clinical trials. Inefficiencies plague the process from discovery throughout the drug development process. Advances in machine learning techniques present a major opportunity for the biopharma industry.

Join us for a discussion with a panel of local leaders in industry and data science. We aim to explore the promise of artificial intelligence and machine learning approaches in drug discovery and development.


Mark Lawson, HemoShear Therapeutics
Amrie Grammer, AMPEL BioSolutions
Kimberly Kelly, ZielBio
Francesca Moraca, Schrodinger

Catherine Williams, Amgen


700 Harris Street Charlottesville, VA
Get Directions